s6y
Company name or ticker
Search
O'Loughlin Steve
4
Actinium Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
Filed
Tuesday, July 17, 2018
Period
Jul 13, 2018
Accession number
0001213900-18-009315
Documents
ownership.xml
4
On sec.gov
Filing index
All files
Complete submission text
SGML header